Serotype distribution, trend of multidrug resistance and prevalence of β-lactamase resistance genes in human Salmonella isolates from clinical specimens in Guizhou, China

PLoS One. 2023 Apr 20;18(4):e0282254. doi: 10.1371/journal.pone.0282254. eCollection 2023.

Abstract

Salmonella, one of the major causes of foodborne infections, can cause bacterial foodborne illness. We investigated the serotype distribution, multidrug resistance (MDR), and β-lactamase resistance genes of human Salmonella isolates collected from clinical specimens in Guizhou, China, between 2013 and 2018. A total of 363 Salmonella isolates were collected from clinical specimens at 17 surveillance hospitals. Twenty-four serotypes were identified by sliding agglutination test. S. Enteritidis (33.9%), Salmonella 4,[5],12:i:- (24.0%), S. Typhimurium (16.3%), S. London (6.3%), and S. Derby (3.9%) were the top five serotypes. In 2018, the most common serotype changed from S. Enteritidis to S. Typhimurium. Among the 363 Salmonella isolates, 97.5% of isolates were resistant to at least one class of antimicrobial agents. For cephalosporins, ceftriaxone had the highest resistance rate of 10.5%, and cefepime and cefoxitin were 8.0% and 2.2%, respectively. Three hundred and one (82.9%) Salmonella isolates showed MDR. Salmonella 4,[5],12:i:- had the highest MDR rate with 94.2%, followed by S. London (91.3%) and S. Typhimurium (88.1%). Multidrug resistance rates of Salmonella isolates in Guizhou from 2013 to 2017 increased from 75.8% to 86.7%. Sixteen isolates (4.4%) showed extensive drug resistance. One hundred thirty-four antimicrobial resistance patterns were found. Two hundred and forty-one (66.4%) isolates carried at least one β-lactamase resistance gene. The blaTEM gene (61.2%) was the most prevalent resistant gene in all Salmonella isolates, followed by the blaCTX-M gene (6.1%) and blaOXA-1 gene (4.1%). Our findings showed that the MDR rate of Salmonella isolates from Guizhou province increased year by year. Therefore, systematic and long-term surveillance on MDR Salmonella isolates from clinical patients should be further strengthened.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • China / epidemiology
  • Drug Resistance, Bacterial
  • Drug Resistance, Multiple, Bacterial* / genetics
  • Humans
  • Microbial Sensitivity Tests
  • Prevalence
  • Salmonella
  • Serogroup
  • beta-Lactam Resistance

Substances

  • Anti-Bacterial Agents

Grants and funding

This research was supported by the Science and Technology Planning Support Project of Guizhou Province (Award Number: Qian Ke He Support [2020]4Y143) Recipient: Xiaoyu Wei, Science and Technology Foundation Planning Project of Guizhou Province (Award Number: Qian Ke He Basis [2017]1094) Recipient: Xiaoyu Wei, and Infectious Disease Prevention and Control Talent Base Scientific Research Team Project of Guizhou Province (Award Number: RCJD2104) Recipient: Xiaoyu Wei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.